Evaluation of left ventricular systolic function in type 2 diabetes mellitus patients with and without peripheral vascular disease

doi:10.4239/wjd.v15.i6.1280

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (331)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-6) series.

Item

Count

PDF

HTML

223

Figures (1-4)

Tables (1-6)

Sum=310

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=18

Jun 15, 2024 (publication date) through Jul 3, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Diabetes. Jun 15, 2024; 15(6): 1280-1290
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1280

Table 1 Clinical parameters of patients among normal controls, type 2 diabetes mellitus patients without peripheral vascular disease and type 2 diabetes mellitus patients with peripheral vascular disease

Clinical parameters	Normal controls (n = 63)	T2DM without PVD (n = 65)	T2DM with PVD (n = 57)	P value
Age, yr	53.29 ± 7.55	54.75 ± 7.72	56.73 ± 7.76	0.053
Male, n (%)	31 (49)	38 (58)	38 (67)	0.103
Height, cm	164.84 ± 7.07	165.83 ± 8.61	164.20 ± 6.98	0.492
Weight, kg	63.56 ± 10.09	68.95 ± 11.76^a	67.32 ± 11.35	0.021
BMI, kg/m²	23.33 ± 2.91	24.97 ± 3.12	24.89 ± 3.40^a	0.005
BSA, m²	1.67 ± 0.16	1.74 ± 0.19	1.71 ± 0.17	0.054
SBP, mmHg	77.90 ± 0.57	82.17 ± 10.81^a	80.18 ± 10.58	0.001
DBP, mmHg	123.38 ± 11.12	132.77 ± 16.29^a	130.70 ± 17.30^a	0.049
HR, bpm	66.95 ± 8.61	75.58 ± 9.91^a	74.80 ± 8.20^a	< 0.001
HbA1c, %	5.48 ± 0.35	9.47 ± 2.39^a	9.94 ± 2.39^a	< 0.001
TC, mmol/L	4.53 ± 0.85	4.36 ± 1.06	4.55 ± 1.03	0.550
TG, mmol/L	1.30 (0.89, 1.80)	1.52 (0.93, 2.43)	1.64 (1.01, 2.07)	0.073
HDL-C, mmol/L	1.25 ± 0.33	1.08 ± 0.29	1.08 ± 0.34	0.013
LDL-C, mmol/L	2.65 ± 0.70	2.58 ± 0.84	2.70 ± 0.83	0.729
LPA, g/L	0.17 (0.09, 0.29)	0.12 (0.06, 0.32)	0.16 (0.09, 0.25)	0.772
FPG, mmol/L	4.99 (4.57, 5.28)	10.02 (7.44, 13.64)^a	10.25 (8.29, 14.07)^a	< 0.001
BUN, mmol/L	4.90 (3.60, 6.40)	5.65 (4.70, 6.58)	6.00 (4.70, 7.40)^a	0.015
SCr, μmol/L	65.00 (56.00, 76.00)	61.00 (51.75, 81.95)	61.70 (52.20, 73.00)	0.772
Medication (%)
ACEI/ARB	-	13 (20)	12 (21)
Calcium channel blocker	-	10 (15)	20 (35)
β-blocker	-	1 (2)	2 (4)
SGLT-2 inhibitor	-	14 (22)	19 (33)
Metformin	-	36 (55)	36 (63)
Insulin	-	41 (63)	42 (74)

^aP < 0.05, indicates significantly different when type 2 diabetes mellitus (T2DM) patients without peripheral vascular disease (PVD) or T2DM patients with PVD compared with the normal controls.

T2DM: Type 2 diabetes mellitus; BMI: Body mass index; BSA: Body surface area; SBP: Systolic blood pressure; DBP: Diastolic blood pressure. HR: Heart rate; FPG: Fasting plasma glucose; HbA1c: Glycated haemoglobin; TC: Total cholesterol; TG: Triglyceride; HDL-C: High density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; LPA: Lipoprotein a; BUN: Blood urea nitrogen; SCr: Serum creatinine.

Table 2 Echocardiographic parameters among normal controls, type 2 diabetes mellitus patients without peripheral vascular disease and type 2 diabetes mellitus patients with peripheral vascular disease

Echocardiographic parameters	Normal controls (n = 63)	T2DM without PVD (n = 65)	T2DM with PVD (n = 57)	P value
LAd, mm	34.42 ± 2.76	35.47 ± 3.25	36.17 ± 3.82^a	0.015
IVSd, mm	9.39 ± 0.74	9.20 ± 0.97	9.27 ± 0.97	0.477
LVPWd, mm	9.05 ± 0.77	8.98 ± 0.99	9.13 ± 1.06	0.685
LVDd, mm	46.35 ± 2.97	45.42 ± 3.60	46.60 ± 3.24	0.110
LVEDV, mL	76.76 ± 14.89	74.02 ± 16.74	78.04 ± 15.98	0.358
LVESV, mL	26.75 ± 6.53	26.12 ± 7.13	26.63 ± 6.47	0.857
LVEF, %	65.19 ± 3.98	64.98 ± 3.39	65.81 ± 4.16	0.478
MAPSE, mm	14.44 ± 1.49	14.16 ± 1.85	13.23 ± 1.87^a^,^b	0.001
E, m/s	0.84 ± 0.13	0.75 ± 0.15^a	0.79 ± 0.13^a	0.001
A, m/s	0.70 ± 0.15	0.74 ± 0.18	0.81 ± 0.17^a^,^b	0.002
E/A	1.24 ± 0.28	1.08 ± 0.34^a	1.01 ± 0.27^a	< 0.001
e′, m/s	0.11 ± 0.02	0.09 ± 0.02^a	0.09 ± 0.02^a	< 0.001
E/e′	8.09 ± 1.54	8.66 ± 1.53	9.45 ± 1.92^a^,^b	< 0.001

^aP < 0.05, indicates significantly different when type 2 diabetes mellitus (T2DM) patients without peripheral vascular disease (PVD) or T2DM patients with PVD compared with the normal controls.

^bP < 0.05, indicates significantly different when T2DM patients with PVD compared with T2DM patients without PVD.

LAd: Left atrial diameter; IVSd: Interventricular septal wall thickness in end-diastolic period; LVPWd: Left ventricular posterior wall thickness in end-diastolic period; LVDd: Left ventricular diameter in end-diastolic period; LVEDV: Left ventricular end-diastolic volume; LVESV: Left ventricular end-systolic volume; LVEF: Left ventricular ejection fraction; MAPSE: Mitral annular plane systolic excursion; E: Peak velocity during early diastole of anterior mitral leaflet; A: Peak velocity during late diastole of anterior mitral leaflet; e′: Peak early diastolic annular velocities using TDI by averaging the values at the septum and lateral positions; PVD: Peripheral vascular disease; T2DM: Type 2 diabetes mellitus.

Table 3 Layer-specific global longitudinal strain and peak strain dispersion among normal controls, type 2 diabetes mellitus patients without peripheral vascular disease and type 2 diabetes mellitus patients with peripheral vascular disease

	Normal controls (n = 63)	T2DM without PVD (n = 65)	T2DM with PVD (n = 57)	P value	P trend
GLSepi, %	-18.65 ± 1.55	-17.37 ± 1.85^a	-16.92 ± 2.21^a	< 0.001	< 0.001
GLSmid, %	-21.57 ± 1.81	-19.98 ± 2.08^a	-19.47 ± 2.50^a	< 0.001	< 0.001
GLSendo, %	-25.03 ± 2.21	-23.12 ± 2.43^a	-22.72 ± 2.85^a	< 0.001	< 0.001
PSD, msec	30.63 ± 7.29	35.03 ± 10.81^a	39.37 ± 12.42^a^,^b	< 0.001	< 0.001

^aP < 0.05, indicates significantly different when type 2 diabetes mellitus (T2DM) patients without peripheral vascular disease (PVD) or T2DM patients with PVD compared with the normal controls.

^bP < 0.05, indicates significantly different when T2DM patients with PVD compared with T2DM patients without PVD.

GLS: Global longitudinal strain; GLSEpi: Global longitudinal strain of the epimyocardial; GLSMid: Global longitudinal strain of the middle myocardial; GLSEndo: Global longitudinal strain of the endomyocardial; PSD: Peak strain dispersion; T2DM: Type 2 diabetes mellitus; PVD: Peripheral vascular disease.

Table 4 Receiver operating characteristic curve analysis for the detection the left ventricular systolic function in type 2 diabetes mellitus patients with peripheral vascular disease

ROC	GLSepi	GLSmid	GLSendo	PSD	Combined
Sensitivity, %	50.88	56.14	66.16	73.68	75.44
Specificity, %	85.71	85.71	77.78	65.08	77.78
Youden index	0.3659	0.4185	0.4094	0.3876	0.5322
AUC (95%CI)	0.735 (0.647-0.811)	0.753 (0.666-0.827)	0.750 (0.663-0.825)	0.735 (0.646-0.811)	0.801 (0.719-0.869)
Associated criterion	-17.0	-19.8	-23.5	32	0.44
P value	0.064	0.127	0.103	0.050

P values mean combined evaluation compare with global longitudinal strain and peak strain dispersion. GLSEpi: Global longitudinal strain of the epimyocardial; GLSMid: Global longitudinal strain of the middle myocardial; GLSEndo: Global longitudinal strain of the endomyocardial; PSD: Peak strain dispersion; ROC: Receiver operating characteristic; AUC: Area under the curve.

Table 5 Correlation test in type 2 diabetes mellitus patients with peripheral vascular disease

Varibles	GLSepi		GLSmid		GLSendo		PSD
Varibles	r value	P value	r value	P value	r value	P value	r value	P value
BMI	0.089	0.510	0.093	0.491	-0.009	0.945	-0.017	0.900
HbA1c	-0.011	0.935	0.028	0.839	-0.019	0.887	-0.225	0.095
TC	0.190	0.158	0.179	0.182	0.040	0.767	0.293	0.027
TG	-0.126	0.349	-0.153	0.257	-0.148	0.271	0.017	0.889
HDL-C	-0.033	0.812	-0.029	0.834	-0.165	0.228	0.093	0.499
LDL-C	0.340	0.010	0.327	0.014	0.204	0.131	0.290	0.030
LPA	0.159	0.254	0.134	0.339	0.184	0.187	-0.103	0.465
BUN	0.293	0.033	0.248	0.074	0.149	0.287	0.292	0.034
SCR	0.301	0.027	0.264	0.053	0.166	0.231	0.205	0.137
LVEF	-0.434	0.001	-0.439	0.001	-0.447	< 0.001	-0.109	0.420
MAPSE	-0.248	0.063	-0.313	0.018	-0.260	0.051	-0.111	0.411

BMI: Body mass index; HbA1c: Glycated haemoglobin; TC: Total cholesterol; TG: Triglyceride; HDL-C: High density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; LPA: Lipoprotein a; BUN: Blood urea nitrogen; SCR: Serum creatinine; GLS: Global longitudinal strain; GLSEpi: Global longitudinal strain of the epimyocardial; GLSMid: Global longitudinal strain of the middle myocardial; GLSEndo: Global longitudinal strain of the endomyocardial; PSD: Peak strain dispersion; LVEF: Left ventricular ejection fraction; MAPSE: Mitral annular plane systolic excursion.

Table 6 Intraclass correlation coefficients for intra- and inter-observer variability for layer specific global longitudinal strain and peak strain dispersion

Variable	Inter-observer variability		Intra-observer variability
Variable	ICC	95%CI	ICC	95%CI
GLSendo	0.955	0.887-0.982	0.964	0.910-0.986
GLSmid	0.963	0.906-0.985	0.970	0.924-0.988
GLSepi	0.960	0.900-0.984	0.970	0.925-0.988
PSD	0.956	0.889-0.983	0.979	0.946-0.992

GLSEpi: Global longitudinal strain of the epimyocardial; GLSMid: Global longitudinal strain of the middle myocardial; GLSEndo: Global longitudinal strain of the endomyocardial; PSD: Peak strain dispersion; ICC: Intraclass correlation coefficient.

Citation: Li GA, Huang J, Fan L. Evaluation of left ventricular systolic function in type 2 diabetes mellitus patients with and without peripheral vascular disease. World J Diabetes 2024; 15(6): 1280-1290
URL: https://www.wjgnet.com/1948-9358/full/v15/i6/1280.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i6.1280